Bringing drug manufacturing back home

Shortages of important drugs like antibiotics and cancer treatments in recent years, as well as disruptions from the Covid-19 pandemic have brought increased attention to the global supply chains involved. This has led to calls for the US and other countries to on-shore manufacturing in the interest of economic stability and even national security. Do they make sense?